Preoperative coronary angiography
OtherIf coronary disease is detected percutaneous intervention (PCI) or coronary artery bypass grafting (CABG) is applied
NCT Number: NCT02260453
The purpose of this study is to evaluate the potential benefit of systematic preoperative coronary angiography followed by selective coronary artery revascularization on the incidence of myocardial infarction (MI) in patients without a history of coronary artery disease (CAD) and undergoing carotid endarterectomy (CEA).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Patients candidates for CEA, with no history of CAD, a normal electrocardiogram (ECG), and a normal cardiac ultrasound were randomized in two groups. In group A (n = 216) all patients underwent coronary angiography before CEA +- coronary artery revascularization. In group B (n = 210) CEA was performed without coronary angiography.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
If coronary disease is detected percutaneous intervention (PCI) or coronary artery bypass grafting (CABG) is applied
EKG, transthoracic cardiac echocardiogram
Time frame: 30 days through year 3
Time frame: 30 days through year 3
University of Roma La Sapienza
Other
Randomized Controlled Trial Analyzing the Role of Systematic Preoperative Coronary Angiography Before Elective Carotid Endarterectomy in Patients With Asymptomatic Coronary Artery Disease
Acronym: CACEA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05416853
Arterial Occlusive Diseases, Brain Diseases
Hefei, Anhui, China
View Trial DetailsNCT05845710
Arterial Occlusive Diseases, Brain Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT03202823
Arterial Occlusive Diseases, Brain Diseases
Dijon, France
View Trial DetailsNCT03982420
Arterial Occlusive Diseases, Brain Diseases
New Haven, Connecticut, United States
View Trial Details